Neuroprotective properties of GLP-1RAs observed in animal models of neurodegenerative diseases such as Alzheimers disease are very often associated with the reduction of inflammatory processes in the central nervous system
Goldman JG, Williams-Gray C, Barker RA, Duda JE, Galvin JE
The medication has demonstrated significant weight loss in clinical trials, with participants losing an average of 12-15% of their body weight over 68 weeks in the STEP clinical trial programme
Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes
Your Transformation Starts Here This isnt just about losing weightits about building a body youre proud of
Again, Ozempic teeth isnt a medical diagnosis, but rather an anecdotal term from GLP-1 users who notice dental issues while taking their medication